Skip to content
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Search
Advanced Search
Sign in
Menu
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Clinical Topics
View All
Addiction
Anxiety
Bipolar Disorder
Depression
Difficult to Treat Depression
Emerging Approaches in Schizophrenia
Neurology
OCD
Psychopharmacology
PTSD and Trauma
Tardive Dyskinesia
View All
Collections
View All
Academic Highlights
Auvelity: Information from Industry
Banner Alzheimer’s Institute
Clinical & Practical Psychopharmacology
Early Career Psychiatrists
Focus on Childhood and Adolescent Mental Health
Focus on Geriatric Psychiatry
Focus on Psychotherapy
Focus on Suicide
Focus on Psychosis
Focus on Women’s Mental Health
Rounds in the General Hospital
View All
Kruti Joshi, MPH
JCP
Original Research
Barriers to Esketamine Nasal Spray Use in Treatment-Resistant Depression
May 6, 2024
Potential barriers to treatment with esketamine nasal spray include travel distance, insurance, low socioeconomic status, and minority communities.
Kruti Joshi
,
Joshua N. Liberman
,
Purva Parab
, et al
JCP
Original Research
Economic Burden of MDD and Suicidality
April 4, 2022
Acute suicidal ideation or behavior (SIB) that accompanies major depressive disorder (MDD) may produce a substantial economic burden. This study evaluated health care resource utilization and costs of commercially...
Dominic Pilon
,
Cheryl Neslusan
,
Maryia Zhdanava
, et al
JCP
Original Research
Prevalence and Burden of TRD and MDD
March 16, 2021
How prevalent is treatment-resistant depression (TRD), and what proportion of the burden of medication-treated major depressive disorder is accounted for by TRD? This study explores those questions using the...
Maryia Zhdanava
,
Dominic Pilon
,
Isabelle Ghelerter
, et al
